0000899243-18-027217.txt : 20181022 0000899243-18-027217.hdr.sgml : 20181022 20181022211555 ACCESSION NUMBER: 0000899243-18-027217 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181018 FILED AS OF DATE: 20181022 DATE AS OF CHANGE: 20181022 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Chereau Frederic CENTRAL INDEX KEY: 0001640592 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38707 FILM NUMBER: 181133147 MAIL ADDRESS: STREET 1: C/O ATYR PHARMA, INC. STREET 2: 3545 JOHN HOPKINS COURT, SUITE 250 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LogicBio Therapeutics, Inc. CENTRAL INDEX KEY: 0001664106 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 471514975 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 700 MAIN STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 61(0)428-338-594 MAIL ADDRESS: STREET 1: 700 MAIN STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-10-18 0 0001664106 LogicBio Therapeutics, Inc. LOGC 0001640592 Chereau Frederic C/O LOGICBIO THERAPEUTICS, INC. 610 MAIN STREET, 3RD FLOOR CAMBRIDGE MA 02139 1 1 0 0 President, CEO Employee Stock Option (right to buy) 10.00 2018-10-18 4 A 0 212525 0.00 A 2028-10-17 Common Stock 212525 212525 D The option becomes exercisable in equal one forty-eighth installments from the vesting commencement date, October 18, 2018. /s/ Matthias Jaffe, as Attorney-in-Fact 2018-10-22